Upcoming Virtual Events
Mar 23
Applications
The role of real-world data in tumor-agnostic drug development
1:00 - 2:00PM EST
Live Q&A
As tumor-agnostic therapies become a new treatment paradigm in oncology, real-world evidence that offers insights into molecular profiles and clinical outcomes in pan-tumor populations is even more vital in the context of precision oncology. This session will showcase industry perspectives highlighted by pre- and post-market use cases to discuss the value of RWE across the tumor-agnostic drug development life cycle.
Event details
